Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiuyi Yu
Observed names:
X. Yu,
Yu, Xiuyi
Institutions:
First Affiliated Hospital of Xiamen University,
Guangzhou Medical University Cancer Hospital,
Guangzhou Medical University
Observed institutions:
First Affiliated Hospital of Xiamen University,
Guangzhou Medical University Cancer Hospital,
Guangzhou Medical University
ORCID:
0009-0007-3472-6263
Observed ORCID:
0009-0007-3472-6263
OpenAlex ID:
A5022219374
Translation regulatory long non‐coding RNA 1 negatively regulates cell radiosensitivity via the miR‐22‐3p/SP1 axis in non‐small cell lung cancer
2024
·
Ming Zhong
, Zheng Fang
, et al.
·
The Clinical Respiratory Journal
·
5
PDF
1884P Surufatinib-based late-line therapy outcomes in recurrent metastatic NSCLC: Monotherapy and vinorelbine combination regimens
2025
·
Y. Zheng
, F. Niu
, et al.
·
Annals of Oncology
Envafolimab combined with albumin-bound paclitaxel and cisplatin in the neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A prospective, single-arm, multicenter phase II study.
2025
·
Zhinuan Hong
, Shijie Huang
, et al.
·
Journal of Clinical Oncology
PDF
1039P Efficacy and safety of surufatinib (HMPL-012) as a third-line or further treatment for advanced non-small cell lung cancer (NSCLC)
2022
·
Y. Zheng
, F. Niu
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
6
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type